HeartSciences HSCS Ratios (2021-2026)

NASDAQ HSCS
$4.23 +0.18 (+4.60%)
As of: Sep 30, 2026 · 9:47 AM EDT
Reported Financials

HeartSciences Quarterly Ratios

Periods 21 quarters
Latest Jul 2026

HeartSciences reported a gross margin of 63.81% and a net margin of -151,064.00% for the quarter ended Jul 2026. These financial ratios cover 21 quarters of results from Jul 2021 through Jul 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Jul2021 Oct2021 Jan2022 Apr2022 Jul2022 Oct2022 Jan2023 Apr2023 Jul2023 Oct2023 Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025 Dec2025 Apr2026 Jul2026
Profitability
Gross Margin
68.83%69.15%36.38%61.03%61.03%68.97%56.78%60.00%58.33%63.81%
EBT Margin
-45,231.90%-49,526.22%-49,178.25%-68,826.05%-44,830.28%-11,182.50%-48,304.62%-108,305.63%-97,269.00%-151,159.57%
EBIT Margin
-40,156.46%-47,669.56%-44,690.53%-67,143.74%-40,254.95%-10,376.75%-44,147.10%-98,637.84%-85,713.23%-139,956.67%
EBITDA Margin
-39,919.38%-47,512.99%-44,490.16%-66,791.69%-40,059.15%-10,351.46%-43,974.39%-98,263.58%-85,423.60%-139,655.14%
Operating Margin
-40,156.46%-47,669.56%-44,690.53%-67,143.74%-40,254.95%-10,376.75%-44,147.10%-98,637.84%-85,713.23%-139,956.67%
Net Margin
-45,200.84%-49,485.08%-49,165.72%-68,826.41%-44,830.21%-11,182.39%-48,145.52%-108,157.58%-97,179.37%-151,064.00%
FCF Margin
-35,265.62%-28,737.58%-56,842.34%-52,486.77%-25,388.18%-14,352.14%-36,566.44%-102,808.79%-96,497.15%-62,802.81%
Efficiency
Inventory AverageInventory Avg.
0.68M0.68M0.68M0.68M0.68M0.68M0.67M0.65M0.64M0.65M0.65M0.65M0.65M0.65M0.65M0.65M0.53M
Assets AverageAssets Avg.
3.83M5.17M4.13M3.38M2.94M2.48M6.58M10.15M8.85M7.98M6.74M4.96M5.33M6.22M5.11M4.74M4.50M
Equity AverageEquity Avg.
-2.93M-3.77M-5.08M-1.58M1.98M0.41M-0.01M-0.14M-1.08M3.49M7.98M6.63M4.98M2.90M1.00M1.67M3.66M2.19M0.22M-0.90M
Invested CapitalInvested Cap.
0.02M4.02M2.21M0.87M1.23M0.48M-0.23M9.13M7.82M6.43M6.43M4.31M2.76M4.68M4.68M2.76M3.85M1.69M
Asset Utilization RatioAsset Util.
0.000.000.000.000.000.000.000.000.000.000.000.000.00
Leverage & Solvency
Interest Coverage RatioInterest Cover
-12.28-7.91-25.67-9.96-54.10-39.91-47.08-36.70-8.80-12.88-89.78-92.15-16.88-13.21-10.62-10.20-7.42-11.11-12.49
Debt Ratio
2.910.200.240.320.300.380.600.050.050.060.310.440.600.240.080.600.691.00
Times Interest Earned
-12.28-7.91-25.67-9.96-54.10-39.91-47.08-36.70-8.80-12.88-89.78-92.15-16.88-13.21-10.62-10.20-7.42-11.11-12.49
Valuation
Price to SalesP/S
0.08M0.20M0.22M0.14M0.05M464.43174.36187.71206.20650.720.00M590.560.00M
Price to BookP/B
293.280.00M0.00M1.110.440.590.721.9519.151.292.2446.2522.65
Enterprise Value
842.51M2,004.39M2,082.41M704.35M951.73M279.11M2.47M-2.56M-0.83M-1.17M0.89M2.83M1.27M7.42M8.39M3.46M7.97M
Market Capitalization
846.78M2,007.47M2,084.35M706.01M952.31M279.21M9.54M3.24M3.51M2.88M3.49M3.93M4.07M9.37M9.49M5.12M8.00M
Return Ratios
Return on Sales [ROS]ROS
-40,156.46%-47,669.56%-44,690.53%-62,276.73%-67,143.74%-118,698.33%-40,254.95%-10,376.75%-33,901.99%-44,687.97%-44,147.10%-98,637.84%-85,713.23%-96,946.89%-139,956.67%
Return on Capital Employed [ROCE]ROCE
-239.03%-309.49%-303.36%-394.16%-575.60%-123.49%-75.07%-94.07%-159.47%-262.27%-662.81%-352.01%-177.18%
Return on Assets [ROA]ROA
-154.18%-129.15%-164.30%-187.84%-208.98%-245.26%-97.07%-65.60%-83.54%-97.01%-128.36%-178.37%-165.34%-145.78%-195.60%-230.00%
Return on Equity [ROE]ROE
-336.31%-1,643.71%-183.04%-83.50%-111.55%-155.68%-298.19%-888.92%-526.71%-247.50%-4,302.43%

HeartSciences Ratios API

Pull HeartSciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=HSCS&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY